Leading the New American Hospital: Strategies for Success

LONDON, May 27, 2016 /PRNewswire/ -- 

Over the last few years hospital inpatient volumes have declined by 5%. During this period ambulatory care revenues have increased by 21%. This trend is indicative of the shifting of care provision away from hospitals. In order to stay competitive in this environment, hospitals need to adopt unique strategies that require greater collaboration with other care providers. There is no "one size fits all" approach that can be adopted across the board. It is imperative that hospitals first identify local population requirements and map them to care provision goals. This is critical in developing strategies for providing low cost, high quality care to patients while ensuring revenue growth.

"Care provision models in the United States are evolving at an unprecedented rate," says Tanvir Jaikishen, Senior Research Analyst, at Frost & Sullivan. "The shift from volume to value based payments, declining inpatient volumes and rise of ambulatory care providers have required hospitals to innovate collaborative models of care delivery that allow them to remain competitive while leveraging collaborations with other care providers."

This Webcast assesses different strategies adopted by hospitals to efficiently manage transition of care provision. Key strategies include smart collaborations with different ambulatory care providers, and adoption of data integration solutions to better create standards of care protocols. Other approaches involve the launch of in-house insurance plans to increase both revenues and patient volumes, as well as adoption of integrated care delivery models like Accountable Care Organizations (ACOs). More hospitals will seek to become part of a full spectrum integrated care ACOs in order to remain competitive. This Webcast will look at some of the factors contributing to this shift as well as assess the impact of ACOs in the future.

Registration:

• To attend the briefing, email Jana Schoeneborn, Corporate Communications, at [email protected] your full contact details.
• Receive a recorded version of the briefing anytime by submitting your contact details.

Supporting Resources

• For more information about Frost & Sullivan's Transformational Healthcare practice, please visit: http://frost.ly/cl

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:
Jana Schoeneborn
Corporate Communications – Europe
P: +49 (0) 69 770 3343
E: [email protected]

Twitter: @FS_Healthcare
Facebook: FrostandSullivan
LinkedIn: Transform Health  

http://www.frost.com

SOURCE Frost & Sullivan